By
Trending Posts
ImmunAI and Teva Partner to Enhance Clinical Trials…
New York, NY – Nov 14, 2024 Strategic Collaboration Aims to Improve Drug Development Efficiency and Patient Outcomes:ImmunAI,…
Medable and Google Cloud Partner to Advance AI-Powered…
PALO ALTO, Calif. – October 30, 2024 Strategic Collaboration to Accelerate Clinical Research Medable Inc., a leader in…
Odyssey and Terray Forge AI-Powered Partnership to Advance…
Boston and Los Angeles – Oct 28, 2024 With Odyssey’s established track record in immunology and Terray’s cutting-edge…
Dyno Therapeutics and Roche Expand Strategic Partnership for…
October 24, 2024 Dyno Therapeutics has expanded its collaboration with Roche to advance next-generation adeno-associated virus (AAV) vectors…
Six Ways Johnson & Johnson is Leveraging AI…
October 10, 2024 Johnson & Johnson is at the forefront of integrating Artificial Intelligence (AI) to drive healthcare…
BullFrog AI Publishes Data Highlighting Potential of BF-114…
Gaithersburg, Md – Oct 9 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company…
ProJenX and Unlearn AI Collaborate to Advance AI-Powered…
San Francisco – September 27, 2024 ProJenX, a clinical-stage biotech company, has partnered with Unlearn AI to enhance…
Novartis and Generate:Biomedicines Announce Strategic AI-Driven Protein Therapeutics…
Somerville, MA — Sept 24, 2024 Combining AI innovation with pharma expertise to accelerate drug development and tackle…
Eli Lilly and Genetic Leap Forge $409M Strategic…
New York – Sept 24 2024 Eli Lilly and Company (NYSE: LLY) has entered into a landmark $409…
Trending Posts
Latest Stories
Can XtalPi & DoveTree’s $6 Billion AI Partnership Transform “Undruggable” Disease Targets in Biopharma – The Dawn of Robotics-Driven R&D at Scale?
Key Highlights: Strategic Overview: Industry’s Largest AI-Pharma CollaborationThis collaboration—one of the biggest in AI-driven drug…
Will CMS’s 2026 WISeR AI Pilot Shift Traditional Medicare’s Access—How Might Algorithmic Prior Authorizations Reshape Patient Outcomes for 30 Million Seniors?
Key Highlights: AI-Powered Prior Authorization: New Model and ScopeCMS’s WISeR (Wasteful and Inappropriate Service Reduction)…
Can Harvard’s FaceAge and Emerging AI Facial Recognition Apps Revolutionize Disease Prediction and Personalized Care in Biopharma and Healthcare?
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge…
How Will BioNTech’s Patent Settlement Impact the Future of mRNA COVID-19 and Influenza Vaccines Globally?
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac…
Gallery
